| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ALK-Rearranged Adenosquamous Lung Cancer Presenting as Squamous Cell Carcinoma: A Potential Challenge to Histologic Type Triaging of NSCLC Biopsies for Molecular Studies
|
Dragnev, Konstantin H.
|
|
2014
|
15 |
3 |
p. e37-e40
nvt p.
|
artikel
|
| 2 |
Clinical Trial Design in Small Cell Lung Cancer: Surrogate End Points and Statistical Evolution
|
Nickolich, Myles
|
|
2014
|
15 |
3 |
p. 207-212
6 p.
|
artikel
|
| 3 |
Clinicopathological Features in Young Patients Treated for Small-Cell Lung Cancer: Significance of Immunohistological and Molecular Analyses
|
Taniyama, Tomoko Katsui
|
|
2014
|
15 |
3 |
p. 244-247
4 p.
|
artikel
|
| 4 |
Concurrent Hyperfractionated Radiation Therapy and Low Dose, Daily Chemotherapy as an Effective and Low Toxicity Approach in Locally Advanced (Stage III) Non–Small-Cell Lung Cancer
|
Jeremić, Branislav
|
|
2014
|
15 |
3 |
p. e31-e32
nvt p.
|
artikel
|
| 5 |
Early Pharmacodynamic Assessment Using 18F-Fluorodeoxyglucose Positron-Emission Tomography on Molecular Targeted Therapy and Cytotoxic Chemotherapy for Clinical Outcome Prediction
|
Kanazu, Masaki
|
|
2014
|
15 |
3 |
p. 182-187
6 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2014
|
15 |
3 |
p. A6-
1 p.
|
artikel
|
| 7 |
Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer
|
von Pawel, Joachim
|
|
2014
|
15 |
3 |
p. 188-196.e2
19413 p.
|
artikel
|
| 8 |
Phase I Trial of Cisplatin, Pemetrexed, and Imatinib Mesylate in Chemonaive Patients With Unresectable Malignant Pleural Mesothelioma
|
Tsao, Anne S.
|
|
2014
|
15 |
3 |
p. 197-201
5 p.
|
artikel
|
| 9 |
Prognostic Factors in the Radical Nonsurgical Treatment of Stage IIIB Non–Small-Cell Lung Cancer
|
Russell, Kent
|
|
2014
|
15 |
3 |
p. 237-243
7 p.
|
artikel
|
| 10 |
Prognostic Implications of Tumoral Expression of Insulin Like Growth Factors 1 and 2 in Patients With Non–Small-Cell Lung Cancer
|
Kim, Jin-Soo
|
|
2014
|
15 |
3 |
p. 213-221
9 p.
|
artikel
|
| 11 |
Prolonged Survival of Patients With Non–Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis in the Modern Treatment Era
|
Riess, Jonathan W.
|
|
2014
|
15 |
3 |
p. 202-206
5 p.
|
artikel
|
| 12 |
Successful Crizotinib Rechallenge After Crizotinib-Induced Interstitial Lung Disease in Patients With Advanced Non–Small-Cell Lung Cancer
|
Asai, Nobuhiro
|
|
2014
|
15 |
3 |
p. e33-e35
nvt p.
|
artikel
|
| 13 |
Table of Contents
|
|
|
2014
|
15 |
3 |
p. A9-A11
nvt p.
|
artikel
|
| 14 |
Thymic Epithelial Neoplasms: A 12-Year Canadian Regional Cancer Program Experience
|
Wheatley-Price, Paul
|
|
2014
|
15 |
3 |
p. 231-236
6 p.
|
artikel
|
| 15 |
Tissue Microarrays in Non–Small-Cell Lung Cancer: Reliability of Immunohistochemically-Determined Biomarkers
|
Pøhl, Mette
|
|
2014
|
15 |
3 |
p. 222-230.e3
229779 p.
|
artikel
|
| 16 |
Treatment of Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation or ALK Gene Rearrangement: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
|
Gridelli, Cesare
|
|
2014
|
15 |
3 |
p. 173-181
9 p.
|
artikel
|
Tijdschrift beschrijving